Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-14

Clinical Trial Update: Effects of Anthocyanin on Skin Health and Markers of Cardiovascular Disease Risk [NA]

View source ↗

Summary

A completed clinical trial from the University of East Anglia studied whether anthocyanin supplementation influences skin health and cardiovascular disease risk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anthocyanin (anthocyanin)

Snippet

Sponsor: University of East Anglia | Conditions: Cardiovascular Disease, Skin Health | NA | Status: COMPLETED